| NUT Carcinoma studied in …STUDIED_INderived13 of 13show fewer |
|---|
| → studied in | NCT07050186Phase 2 · recruiting Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma · condition mapped CURATED_BROADER · 13 trials mapped (8 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05019716Phase 1/Phase 2 · recruiting Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma · condition mapped CURATED_BROADER · 13 trials mapped (8 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05372640Phase 1 · recruiting Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors · condition mapped CURATED_BROADER · 13 trials mapped (8 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07459127active not recruiting Multicenter Retrospective Cohort of Pulmonary NUT Carcinoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05812027active not recruiting A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05265429recruiting Biology of Young Lung Cancer Study: The YOUNG LUNG Study · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07072143recruiting An International Study on Pediatric Patients With Rare Tumors. · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05488548Phase 1 · recruiting Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02516553Phase 1 · completed BI 894999 First in Human Dose Finding Study in Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 13 trials mapped (8 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02698176Phase 1 · terminated A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Advanced Solid Tumors (MK-8628-006) · condition mapped ALIAS · 13 trials mapped (8 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02259114Phase 1 · completed A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003) · condition mapped ALIAS · 13 trials mapped (8 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04116359Phase 1/Phase 2 · withdrawn Testing of the Addition of a New Anti-cancer Drug, Molibresib, to Chemotherapy Treatment (Etoposide and Cisplatin) for Patients With NUT Carcinoma · condition mapped CURATED_BROADER · 13 trials mapped (8 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02307240Phase 1 · completed Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors · condition mapped ALIAS · 13 trials mapped (8 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |